News & Events

Toft Group Completes Search for Senior Director of Laboratory Operations for CareDx, Inc. (Nasdaq: CDNA) in Brisbane, CA

Executive search firm Toft Group has placed Ms. Mariko Matsutani as Senior Director of Laboratory Operations for CareDx Inc. in Brisbane, CA.

Ms. Matsutani is a licensed clinical laboratory scientist and medical technologist with over 25 years of experience in her field. She joined Trovagene in 2014 as Director of Clinical Laboratory Operations where she oversaw daily operations of a CLIA, CAP-accredited laboratory. Previously, Ms. Matsutani worked with Biotheranostics as an Administrative Director, Laboratory Operations. Ms. Matsutani served with Cypress Biosciences as their Director, Clinical Laboratory, oversaw the clinical laboratory of Prometheus Laboratories, and was a Senior Clinical Laboratory Scientist at Scripps Research Institute.

Ms. Matsutani holds a BS in medical technology from Northern Arizona University.

About CareDx

CareDx, Inc. (Nasdaq: CDNA), headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products along the pre- and post-transplant testing continuum.

Toft Group Executive Search Named in the Top 50 Recruiters in the Americas

June 4, 2018, San Diego, CA:  Toft Group, a global life sciences and healthcare executive recruiting firm, today announced it has been named one of the Top 50 Recruiters in the Americas by Hunt Scanlon Media, the most widely referenced global news source in the human capital sector. Hunt Scanlon recently presented its annual roundup of the largest, fastest-growing executive search firms in the Americas. These are the 50 top firms in this dynamic marketplace – ranging from the largest recruiting and talent leadership solutions firms to the leading boutique specialists.

The complete list of search firms was published in the Recruiters Rankingsspecial issue of the Hunt Scanlon Executive Search Review.

“Toft Group is honored to be recognized among the top recruiters,” commented Robin Toft, President & CEO of Toft Group. “As today’s talent gap has become a hiring crisis, the need for experienced and talented executive search professionals has grown. Our success comes from our team of highly experienced search consultants, our commitment to delivering exceptional results and our collaborative network of partners, clients, and candidates who share a passion for healthcare advancements and innovation.”

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston. For more information, visit

About Hunt Scanlon Media

Hunt Scanlon Media has been informing the senior talent management sector for over 25 years. Their global news and intelligence data comes in many forms, including daily newswires, talent leadership reports, newsletter briefings and social media alerts. The privately-held company is headquartered in Greenwich, Conn.

Toft Group Completes Search for Vice President, Clinical Affairs for Kiyatec, Inc. in Greenville, SC

Executive search firm Toft Group has placed Charlene Knape as Vice President, Clinical Affairs for Kiyatec, Inc. in Greenville, SC.

Ms. Knape is a clinical operations executive with many years of industry experience, primarily within diagnostics and medical devices. She recently served as Senior Director, Clinical Development for Inivata, a privately-held company developing liquid biopsy assays analyzing cancer genomics. Prior to this, Ms. Knape worked for Becton Dickinson in their Diagnostic BioSpecimen Solutions group. In this role, she was responsible for sourcing rare samples including TB+ sputum, breast cancer, and cervical cancer from local sources and developing countries to support internal R&D development programs. Previously, Ms. Knape worked with Micell Technologies, LabCorp, EndoTex Interventional Systems, Avocet Medical and Somnus Medical Technologies. Ms. Knape holds an M.T. degree in medical laboratory sciences from Michener Applied Health Sciences in Toronto.

About Kiyatec, Inc.

Kiyatec, Inc. offers cell-based Drug Response Profiling (DRP) services to help pharmaceutical and biotech companies accelerate the development of their small molecule compounds and biologic drugs. Their scientific team routinely performs advanced three-dimensional (3D) cell-based assays using immortalized cell lines, patient-derived xenograft (PDX) tissues or clinically sourced primary cancer tissues, including rare tumors, to better predict in vivo response.  Their 3D tumor models are being used to identify in vitro drug response across a broad array of therapeutic classes and biological targets.